Detection of the ERalpha/Src/PI3K Complex as Predictive Marker in Breast Cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150212087A1
SERIAL NO

14417269

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Detection of the ERα/Src/PI3K complex by a Proximity ligation assay as prognostic and theranostic marker in breast cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE75016 PARIS
UNIVERSITE CLAUDE BERNARD LYON 143 BOULEVARD DU 11 NOVEMBRE 1918 VILLEURBANNE 69100
CENTRE LEON BERARD69008 LYON
LNSTITUT NATIONAL DE IA SANTE ET DE IA RECHERCHE MEDICALE101 RUE DE TOLBIAC PARIS 75013

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Le, Romancer-Cherifi Muriel Sainte Foy Les Lyon, FR 2 2
Tredan, Olivier Ecully, FR 2 2
Treilleux, Isabelle Lyon, FR 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation